What is HIV/AIDS?
HIV (human immunodeficiency virus) weakens the immune system by destroying cells that fight infections. The virus progresses in three stages:
- Acute HIV
- Clinical latency
- AIDS (acquired immunodeficiency syndrome)
During the final stage, patients are highly vulnerable to severe illnesses, known as opportunistic infections. While there’s currently no known cure for HIV/AIDS, proper care – including antiretroviral therapy (ART) – can help control the virus. In fact, life expectancy among ART patients nearly matches that of the general population.
Still, many patients face barriers to care or struggle with medication side effects such as loss of appetite, depression, nausea, and insomnia.
Marijuana & HIV/AIDS
Cannabis has long been recognized for easing symptoms of HIV/AIDS and side effects of ART. According to a 2004 study in the Journal of Acquired Immune Deficiency Syndromes, patients reported marijuana use helped relieve anxiety, depression, nausea, and appetite loss – all key issues affecting ART adherence.
FDA-approved dronabinol (Marinol), a synthetic form of THC, is prescribed to treat HIV-related appetite loss. Supporting research in the Journal of Analytical Toxicology validates its role.
But cannabis may offer more than symptom relief. A 2012 non-human primate study found chronic THC use reduced viral load, inflammation, and mortality in monkeys with an HIV-like virus known as SIV.
Researchers believe marijuana’s anti-inflammatory effects may play a key role. HIV triggers immune responses that release inflammatory cytokines. THC appears to reduce this reaction by suppressing cytokine production and limiting immune cell damage. Cannabis may also suppress HIV replication by reducing neuroinflammation.
Florida HIV/AIDS & Cannabis Research
In 2017, the National Institute on Drug Abuse awarded the University of Florida a $3.2 million grant to study marijuana and HIV. Principal investigator Dr. Robert L. Cook explained:
Though clinical trials on THC’s direct effects are limited, the UF team is measuring marijuana’s impact on viral load and inflammation in 400 HIV-positive Floridians over five years. (For more details, visit UF Health.)
What Patients Are Saying
Former San Francisco Assistant District Attorney Keith Vines has shared:
Doctor and author Kate Scannell echoes this sentiment:
Marijuana & HIV/AIDS Studies
Roughly one million Americans live with HIV. Thanks to antiretroviral therapy (ART), many now enjoy near-normal lifespans into their 70s. However, ART isn’t without side effects. According to the CDC, these can include nausea, weight loss, pain, and depression. That’s where medical marijuana comes in.
A Journal of Pain and Symptom Management study found cannabis use improved:
- Appetite (97%)
- Muscle pain (94%)
- Nausea (93%)
- Anxiety (93%)
- Nerve pain (90%)
- Depression (86%)
- Paresthesia (85%)
Emerging research also indicates marijuana may help fight HIV itself. Data from animal studies suggest cannabinoids can reduce inflammation and limit the release of harmful toxins.
That’s especially important given the role of chronic inflammation in HIV-related complications, such as cardiovascular disease, cognitive decline, and diabetes. The anti-inflammatory effects of cannabis are well-documented and are being explored further in human studies.
One study in Clinical Infectious Diseases found cannabis use correlated with reduced inflammation and immune activation in HIV patients on ART. Additional research shows cannabis may reduce CD4 cell depletion by suppressing cytokines.
As noted in Future Medical Chemistry: